Union City, CA, United States of America

Ruihuan Chen

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ruihuan Chen: Innovator in Pharmaceutical Chemistry

Introduction

Ruihuan Chen is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical health issues.

Latest Patents

Ruihuan Chen holds 2 patents, including a groundbreaking invention related to a 2,4,6-trisubstituted s-triazine compound. This compound is represented by a general formula and includes pharmaceutically acceptable salts, prodrugs, or solvates. The preparation method and use of these compounds are aimed at developing drugs for preventing or treating diseases associated with protein kinase and vimentin dysregulation, as well as cell vacuolization. Notably, these drugs are intended for treating or preventing cancer growth and metastasis, tissue fibrosis, and atherosclerosis.

Career Highlights

Throughout his career, Ruihuan Chen has worked with several prominent companies, including Aluda Pharmaceuticals, Inc. and Nanjing Shiqi Pharmaceutical Co. Ltd. His work has been instrumental in advancing pharmaceutical research and development.

Collaborations

Ruihuan Chen has collaborated with esteemed colleagues such as Qizheng Yao and Jianping Wu. These partnerships have contributed to the success of his innovative projects.

Conclusion

Ruihuan Chen's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in drug development and treatment options for critical health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…